Last edition
News about "Once-yearly lenacapavir"
Gilead Accelerates Access to Once-Yearly HIV Drug
Gilead speeds global access for once-yearly HIV drug lenacapavir, signing 6 royalty-free licensing deals for supplying in 120 high-incidence countries.
Once-yearly Lenacapavir | 18/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members